© 2026 Iowa Public Radio
Play Live Radio
Next Up:
0:00
0:00
0:00 0:00
Available On Air Stations

Moderna and Merck's mRNA vaccine reduces melanoma recurrence by 42%

Moderna and Merck recently released remarkable new results of their personalized cancer vaccine.

Here & Now‘s Scott Tong speaks with Matthew Herper, a senior writer at STAT, the health and science publication.

This article was originally published on WBUR.org.

Copyright 2026 WBUR

Your evening news, delivered.

Close your day with the top stories from NPR and the latest on what's happening in Iowa.